Foundational characteristics of cancer include proliferation, angiogenesis, migration, evasion of apoptosis, and cellular immortality. Find key markers for these cellular processes and antibodies to detect them.
The SUMOplot™ Analysis Program predicts and scores sumoylation sites in your protein. SUMOylation is a post-translational modification involved in various cellular processes, such as nuclear-cytosolic transport, transcriptional regulation, apoptosis, protein stability, response to stress, and progression through the cell cycle.
The Autophagy Receptor Motif Plotter predicts and scores autophagy receptor binding sites in your protein. Identifying proteins connected to this pathway is critical to understanding the role of autophagy in physiological as well as pathological processes such as development, differentiation, neurodegenerative diseases, stress, infection, and cancer.
CHST5 Antibody (C-term) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
| Primary Accession | Q9GZS9 |
|---|---|
| Clone Names | 110826077 |
| Gene ID | 23563 |
|---|---|
| Other Names | Carbohydrate sulfotransferase 5, 282-, Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 4-alpha, GST4-alpha, Intestinal N-acetylglucosamine-6-O-sulfotransferase, I-GlcNAc6ST, Intestinal GlcNAc-6-sulfotransferase, hIGn6ST, N-acetylglucosamine 6-O-sulfotransferase 3, GlcNAc6ST-3, Gn6st-3, CHST5 |
| Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
| Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
| Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
| Name | CHST5 |
|---|---|
| Function | Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the transfer of sulfate to position 6 of non-reducing N-acetylglucosamine (GlcNAc) residues and O- linked sugars of mucin-type acceptors. Acts on the non-reducing terminal GlcNAc of short carbohydrate substrates. However, it does not transfer sulfate to longer carbohydrate substrates that have poly-N- acetyllactosamine structures. Has no activity toward keratan. Not involved in generating HEV-expressed ligands for SELL. Its substrate specificity may be influenced by its subcellular location. |
| Cellular Location | Golgi apparatus membrane; Single-pass type II membrane protein. Note=Golgi membrane, early secretory pathway |
| Tissue Location | Predominantly expressed in small and large intestines and colon. Weakly expressed in lymphocytes. Not expressed in other tissues. Down-regulated in colonic adenocarcinomas |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
The carbohydrates of glycoconjugates are highly diversestructures with variation in monosaccharide composition, glycosidiclinkage positions, and branching of chains. Further diversity isadded by the covalent addition of sulfate moieties to particularhydroxyl groups and amino groups of saccharides. The sulfatemodifications of glycoproteins can be extensive in amount andfrequently occur at high density. They can have a profound effecton the physiochemical properties of the glycoconjugates, at leastin part through the addition of negative charge. Carbohydratesulfation plays a critical role in many biologic processes. CHST5belongs to the GST family of sulfotransferases, which also includesCHST1 (MIM 603797), CHST2 (MIM 603798), CHST3 (MIM 603799), andLSST. These enzymes are 6-O-sulfotransferases, which add sulfate toC6 of galactose (Gal), N-acetylgalactosamine (GalNAc), orN-acetylglucosamine (GlcNAc) (Lee et al., 1999 [PubMed10491328]).
References
Liu, C.Y., et al. Carcinogenesis 31(7):1259-1263(2010)Dastani, Z., et al. Eur. J. Hum. Genet. 18(3):342-347(2010)Saito, A., et al. J. Hum. Genet. 54(6):317-323(2009)Kitayama, K., et al. J. Biol. Chem. 282(41):30085-30096(2007)Lamesch, P., et al. Genomics 89(3):307-315(2007)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.
Ordering Information
Shipping Information
